Per 25 mcg/125 mcg actuation Salmeterol xinafoate 25 mcg, fluticasone propionate 125 mcg. Per 25 mcg/250 mcg actuation Salmeterol xinafoate 25 mcg, fluticasone propionate 250 mcg
Indications/Uses
Asthma where use of combination (long acting β2-agonist & inhaled corticosteroid) is appropriate: Patients not adequately controlled w/ inhaled corticosteroids & as needed inhaled short-acting β2-agonist or those already controlled on both inhaled corticosteroids & long-acting β2-agonist.
R03AK06 - salmeterol and fluticasone ; Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.